Clinical trial
Dose Ranging Study in Elective Total Hip Replacement Surgery
NCT00338897 · Sanofi, Industry · Completed
Key facts
| NCT number | NCT00338897 |
|---|---|
| Title | Dose Ranging Study in Elective Total Hip Replacement Surgery |
| Official title | A Multicenter, Randomized, Double-Blind, Double Dummy, Parallel Group, Dose Ranging Study of Subcutaneous SR123781A With an Enoxaparin Calibrator Arm in the Prevention of Venous Thromboembolism in Patients Undergoing Elective Total Hip Replacement Surgery |
| Acronym | DRIVE |
| Lead sponsor | Sanofi, Industry |
| Status | Completed |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | Venous Thromboembolism |
| Intervention type | Drug |
| Interventions | SR123781A |
| Enrollment | 1,090 |
| Start date | May 1, 2006 |
| Primary completion | May 1, 2007 |
| Completion | May 1, 2007 |
| First posted | Jun 20, 2006 |
| Last update posted | Dec 10, 2008 |
| Countries | Argentina, Bulgaria, Chile, Colombia, Czechia, Denmark, Finland, Mexico, Norway, Poland, Romania, Russia and 2 more |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: